No­var­tis CEO Vas Narasimhan re­struc­tures the phar­ma gi­ant, cut­ting costs $1B+, oust­ing top ex­ecs and sig­nal­ing ...

4 years ago
Pharma

A Penn spin­out goes dark; Thumbs down on ALS drug; TIG­IT runs in­to PhI­II flop; Sanofi's got big plans; and more

4 years ago
Weekly

Sage touts pos­i­tive ear­ly sig­nals in Alzheimer's. Will they be able to re­peat it in a blind­ed study?

4 years ago
R&D
Pharma

Scoop: A Penn Parkin­son's spin­out goes dark as ex-FDA com­mish Hahn jumps off board

4 years ago
Startups

Mid­dle of the road for CEOs: Bris­tol My­er­s' Gio­van­ni Caforio se­cured al­most $20M in 2021 com­pen­sa­tion

4 years ago
People
Pharma

Har­vard sci­en­tist Charles Lieber seeks ac­quit­tal in 'ill-con­ceived' Chi­na Ini­tia­tive case

4 years ago
People
China

On­tario antes up $580M for C&G ther­a­py plant in Hamil­ton

4 years ago
Pharma
Manufacturing

In Lil­ly so­cial me­dia video se­ries, em­ploy­ees open up about Alzheimer's per­son­al ties — and in­spi­ra­tion

4 years ago
Pharma
Marketing

More biosim­i­lar use could've saved Medicare and ben­e­fi­cia­ries $84M in 2019, HHS OIG says

4 years ago
FDA+

Seagen CEO Clay Sie­gall hauls in more than most Eu­ro­pean coun­ter­parts and Mod­er­na's Ban­cel

4 years ago
People
Pharma

Sanofi's plan to list its API spin­out in France is a go

4 years ago
Pharma
Manufacturing

Mer­ck­'s pneu­mo­coc­cal vac­cine suf­fers PDU­FA de­lay in pe­di­atric pop­u­la­tion, with Pfiz­er hot on its tail

4 years ago
R&D
FDA+

Covid-19 roundup: Con­gress re­port­ed­ly near­ing $10B fund­ing deal; Mer­ck and Ridge­back tout new mol­nupi­ravir da­ta

4 years ago
Coronavirus

Most Chi­nese firms could keep their US list­ings un­der draft frame­work — re­port

4 years ago
China
Pharma

In­spired by Break­ing Bad to make ricin, ex-biotech ex­ec sen­tenced for ly­ing to FBI

4 years ago
People

Sil­ver­back falls on hard times, ax­ing lead I/O can­di­dates and lay­ing off more than a fourth of staff

4 years ago
R&D

Changes in high-rank­ing ex­ecs poised to deep­en at Karyopharm; Till­man Gern­gross-chaired biotech pro­motes new med­ical ...

4 years ago
Peer Review

House pass­es $35 month­ly in­sulin caps, but Sen­ate re­mains a ques­tion mark

4 years ago
Pharma

FDA chief Rob Califf: The busi­ness of health is boom­ing but peo­ple's out­comes aren't im­prov­ing

4 years ago
FDA+

Rick Gon­za­lez stays in the win­ners cir­cle at Ab­b­Vie, grab­bing $24M comp pack­age

4 years ago
Pharma

Bio­haven’s top sci­en­tist stars in new ‘Idea­haven’ mi­graine cam­paign, adding to its mar­ket­ing bag of tricks

4 years ago
Pharma
Marketing

DoJ ‘Chi­na Ini­tia­tive’ probe in­to stem cell pi­o­neer Haifan Lin dis­con­tin­ued, lawyer says

4 years ago
People

Clo­vis On­col­o­gy her­alds a PARP vic­to­ry in front­line ovar­i­an can­cer — does any­one re­al­ly care much?

4 years ago
Bioregnum
Pharma

Flori­da be­comes next state to seal big opi­oid set­tle­ment deal, bag­ging $878M from Te­va, Al­ler­gan and oth­ers

4 years ago
Pharma
First page Previous page 556557558559560561562 Next page Last page
A service from the Financial Times